Related Experiment Video
Updated: Aug 20, 2026

Invasion of Human Cells by a Bacterial Pathogen
Published on: March 21, 2011
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens
Gunnar Lindahl1, Margaretha Stålhammar-Carlemalm, Thomas Areschoug
1Department of Medical Microbiology, Dermatology and Infection, Lund University, Sölvegatan 23, SE-22362 Lund, Sweden. gunnar.lindahl@mmb.lu.se
Insights
Group B Streptococcus causes serious neonatal infections. Research highlights surface proteins as promising vaccine targets, offering potential for new prevention strategies against this major bacterial pathogen.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Streptococcus agalactiae (group B Streptococcus) is a primary cause of invasive bacterial disease in neonates.
- While prophylactic measures have reduced infections, a vaccine is still needed.
- The S. agalactiae polysaccharide capsule is a known virulence factor and target for protective immunity.
Purpose of the Study:
- To summarize current knowledge on S. agalactiae surface proteins.
- To focus on proteins with characterized immunochemistry and/or those eliciting protective immunity in animal models.
- To explore the potential of these surface proteins as vaccine components.
Main Methods:
- Review of existing literature on S. agalactiae surface proteins.
- Analysis of immunochemical characterization data.
- Evaluation of protective immunity data from animal models.
Main Results:
- S. agalactiae surface proteins are involved in host cell interactions, extracellular matrix binding, and immune evasion.
- Several surface proteins are homologous to those found in other bacterial pathogens.
- Some S. agalactiae surface proteins have demonstrated the ability to elicit protective immunity in animal studies.
Conclusions:
- S. agalactiae surface proteins are significant virulence factors and potential vaccine candidates.
- These proteins offer promise for developing novel vaccines, either as standalone protein-based vaccines or as carriers in conjugate vaccines.
- Further research into S. agalactiae surface proteins could lead to effective prevention strategies against neonatal infections.
Abstract:
Streptococcus agalactiae (group B Streptococcus) is the major cause of invasive bacterial disease, including meningitis, in the neonatal period. Although prophylactic measures have contributed to a substantial reduction in the number of infections, development of a vaccine remains an important goal. While much work in this field has focused on the S. agalactiae polysaccharide capsule, which is an important virulence factor that elicits protective immunity, surface proteins have received increasing attention as potential virulence factors and vaccine components. Here, we summarize current knowledge about S. agalactiae surface proteins, with emphasis on proteins that have been characterized immunochemically and/or elicit protective immunity in animal models. These surface proteins have been implicated in interactions with human epithelial cells, binding to extracellular matrix components, and/or evasion of host immunity. Of note, several S. agalactiae surface proteins are related to surface proteins identified in other bacterial pathogens, emphasizing the general interest of the S. agalactiae proteins. Because some S. agalactiae surface proteins elicit protective immunity, they hold promise as components in a vaccine based only on proteins or as carriers in polysaccharide conjugate vaccines.
Related Concept Videos
Determinants of Bacterial Pathogenicity and Virulence
Staphylococcal Skin Infections
Streptococcal Pharyngitis
Cytoskeletal Proteins in Bacteria
Outer Layers of the Cell Envelope
Formation of Lipopolysaccharides
